GM-CSF promotes migration of human monocytes across the blood brain barrier

European Journal of Immunology

Volumn 45, Issue 6, 2015, Pages 1808-1819

  Vogel, Daphne Y S ^a   Kooij, Gijs ^a   Heijnen, Priscilla D A M ^a   Breur, Marjolein ^a   Peferoen, Laura A N ^a   van der Valk, Paul ^a   de Vries, Helga E ^a   Amor, Sandra ^a,b   Dijkstra, Christine D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

CNS; Macrophages; Migration; Monocytes; MS

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; CYTOKINE; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TISSUE; CELL ACTIVATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MALE; MICROGLIA; MICROGLIAL CELL CULTURE; MONOCYTE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; WHITE MATTER LESION; AGED; BRAIN; CELL CULTURE; DRUG EFFECTS; ENDOTHELIUM CELL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD-BRAIN BARRIER; BRAIN; CELLS, CULTURED; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICROGLIA; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS; REACTIVE OXYGEN SPECIES; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84930415700     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444960     Document Type: Article

References (54)

1. Lassmann, H., Pathology of multiple sclerosis. In: McAlpine's MS, 3rd edn., Churchill Livingstone, London, 1998.
2. DeGroot, C. J., Bergers, E., Kamphorst, W., Ravid, R., Polman, C. H., Barkhof, F. and vander Valk P., Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 2001. 124: 1635-1645.
3. Kuhlmann, T., Lingfeld, G., Bitsch, A., Schuchardt, J. and Brück, W., Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002. 125: 2202-2212.
4. Brück, W., The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J. Neurol. 2005. 252(Suppl 5): v3-v9.
5. Huitinga, I., vanRooijen, N., deGroot, C. J., Uitdehaag, B. M. and Dijkstra, C. D., Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 1990. 172: 1025-1033.
6. Tran, E. H., Hoekstra, K., vanRooijen, N., Dijkstra, C. D. and Owens, T., Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 1998. 161: 3767-3775.
7. Engelhardt, B. and Kappos, L., Natalizumab: targeting alpha4-integrins in multiple sclerosis. Neurodegener. Dis. 2008. 5: 16-22.
8. Hamilton, J. A. and Anderson, G. P., GM-CSF biology. Growth Factors 2004. 22: 225-231.
9. Hamilton, J. A., Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 2008. 8: 533-544.
10. Fleetwood, A. J., Cook, A. D. and Hamilton, J. A., Functions of granulocyte-macrophage colony-stimulating factor. Crit. Rev. Immunol. 2005. 25: 405-428.
11. Schäbitz, W-R., Krüger, C., Pitzer, C., Weber, D., Laage, R., Gassler, N., Aronowski, J. et al., A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J. Cereb. Blood Flow Metab. 2008. 28: 29-43.
12. Giulian, D., Li, J., Li, X., George, J. and Rutecki, P. A., The impact of microglia-derived cytokines upon gliosis in the CNS. Dev. Neurosci. 1994. 16: 128-136.
13. Ambarus, C. A., Krausz S, vanEijk, M., Hamann, J, Radstake, T. R. D. J., Reedquist, K. A., Tak, P. P. et al., Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J. Immunol. Methods 2012. 375: 196-206.
14. Vogel, D. Y. S., Glim, J. E., Stavenuiter, A. W. D., Breur, M., Heijnen, P., Amor, S., Dijkstra, C. D. et al., Human macrophage polarization in vitro: maturation and activation methods compared. Immunobiology. 2014. DOI:10.1016/j.imbio.2014.05.002 9: 695-703.
15. Ottow, M. K., Klaver, E. J., vander Pouw Kraan, T. C. T. M., Heijnen, P. D., Laan, L. C., Kringel, H, Vogel, D. Y. S. et al., The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages. Genes Immun. 2014. DOI: 10.1038/gene.2014.38 7: 477-486.
16. Verreck, F. A. W, deBoer, T, Langenberg, D. M. L, Hoeve, M. A., Kramer, M., Vaisberg, E., Kastelein, R. et al., Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl. Acad. Sci. USA 2004. 101: 4560-4565.
17. Lee, S. C., Liu, W., Brosnan, C. F. and Dickson, D. W., GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia 1994. 12: 309-318.
18. Dame, J. B., Christensen, R. D. and Juul, S. E., The distribution of granulocyte-macrophage colony-stimulating factor and its receptor in the developing human fetus. Pediatr. Res. 1999. 46: 358-366.
19. McLay, R. N., Kimura, M., Banks, W. A. and Kastin, A. J., Granulocyte-macrophage colony-stimulating factor crosses the blood-brain and blood-spinal cord barriers. Brain 1997. 120 (Pt 11):2083-2091.
20. Ha Y, Kim, Y. S., Cho, J. M., Yoon, S. H., Park, S. R., Yoon, D. H., Kim, E. Y. et al., Role of granulocyte-macrophage colony-stimulating factor in preventing apoptosis and improving functional outcome in experimental spinal cord contusion injury. J. Neurosurg. Spine 2005, 2: 55-61.
21. Carrieri, P. B., Provitera, V., DeRosa, T., Tartaglia, G., Gorga, F. and Perrella, O., Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity. Immunopharmacol. Immunotoxicol. 1998. 20: 373-382.
22. McQualter, J. L., Darwiche, R., Ewing, C., Onuki, M., Kay, T. W., Hamilton, J. A., Reid, H. H. et al., Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 2001. 194: 873-882.
23. Codarri, L., Gyülvészi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T. et al., RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011. 12: 560-567.
24. Marusic, S., Miyashiro, J. S., Douhan, J., 3rd, Konz, R. F., Xuan, D., Pelker, J. W., Ling, V. et al., Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in mice. Neurosci. Lett. 2002. 332: 185-189.
25. MorphoSys, A., Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis. ClinicalTrials.gov. 20140214. Available at: https://clinicaltrials.gov/ct2/show/NCT01517282.
26. Ponomarev, E. D., Shriver, L. P., Maresz, K., Pedras-Vasconcelos, J. and Verthelyi, D., Dittel, B. N., GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 2007. 178: 39-48.
27. Shang, X. Z. and Issekutz, A. C., Enhancement of monocyte transendothelial migration by granulocyte-macrophage colony-stimulating factor: requirement for chemoattractant and CD11a/CD18 mechanisms. Eur. J. Immunol. 1999. 29: 3571-3582.
28. Weksler, B. B., Subileau, E. A., Perrière, N., Charneau, P., Holloway, K., Leveque, M., Tricoire-Leignel, H. et al., Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 2005. 19: 1872-1874.
29. Sørensen, T. L., Ransohoff, R. M., Strieter, R. M. and Sellebjerg, F., Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. Eur. J. Neurol. 2004. 11: 445-449.
30. Vander Goes, A., Wouters, D., VanDer Pol, S. M., Huizinga, R., Ronken, E., Adamson, P., Greenwood, J. et al., Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. FASEB J. 2001. 15: 1852-1854.
31. Wiggins-Dohlvik, K., Merriman, M., Shaji, C. A., Alluri, H., Grimsley, M., Davis, M. L., Smith, R. W. et al., Tumor necrosis factor-α disruption of brain endothelial cell barrier is mediated through matrix metalloproteinase-9. Am. J. Surg. 2014. DOI: 10.1016/j.amjsurg.2014.08.014 6: 954-960.
32. Vogel, D. Y. S., Vereyken, E. J. F, Glim, J. E., Heijnen, P. D. A. M., Moeton, M., vander Valk, P., Amor, S. et al., Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J. Neuroinflammation 2013. 10: 35.
33. Mikita, J., Dubourdieu-Cassagno, N., Deloire, M. S., Vekris, A., Biran, M., Raffard, G., Brochet, B. et al., Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 2011. 17: 2-15.
34. Shechter, R., Schwartz, M., Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer "if" but "how." J. Pathol. 2013. 229: 332-346.
35. Miron, V. E., Boyd, A., Zhao J-W, Yuen, T. J., Ruckh, J. M., Shadrach, J. L., vanWijngaarden, P. et al., M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 2013. 16: 1211-1218.
36. Fife, B. T., Huffnagle, G. B., Kuziel, W. A. and Karpus, W. J., CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 2000. 192: 899-905.
37. Durafourt, B. A., Moore, C. S., Zammit, D. A., Johnson, T. A., Zaguia, F., Guiot, M-C, Bar-Or, A. et al., Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 2012. 60: 717-727.
38. Martinez, F. O. and Gordon, S., The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014. 6: 13 3: 6-13.
39. Qin, H., Wilson, C. A., Lee, S. J., Zhao, X. and Benveniste, E. N., LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. Blood 2005. 106: 3114-3122.
40. Martinez, F. O., Sica, A., Mantovani, A. and Locati, M., Macrophage activation and polarization. Front. Biosci. 2008. 13: 453-461.
41. Vander Goes, A., Brouwer, J., Hoekstra, K., Roos, D., vanden Berg, T. K. and Dijkstra, C. D., Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J. Neuroimmunol. 1998. 92: 67-75.
42. Verreck, F. A. W., deBoer, T., Langenberg, D. M. L., vander Zanden, L. and Ottenhoff, T. H. M., Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J. Leukoc. Biol. 2006. 79: 285-293.
43. Melief, J., Koning, N., Schuurman, K. G., VanDe Garde, M. D. B., Smolders, J., Hoek, R. M., VanEijk, M. et al., Phenotyping primary human microglia: tight regulation of LPS responsiveness. Glia 2012. 60: 1506-1517.
44. Haider, L., Fischer, M. T., Frischer, J. M., Bauer, J., Höftberger, R., Botond, G., Esterbauer, H. et al., Oxidative damage in multiple sclerosis lesions. Brain 2011. 134: 1914-1924.
45. Vogel, D. Y. S., Heijnen, P. D. A. M., Breur, M., deVries, H. E., Tool, A. T. J, Amor, S. and Dijkstra, C. D., Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation. J. Neuroinflammation 2014. 1: 11-23.
46. Kooij, G., Kroon, J., Paul, D., Reijerkerk, A., Geerts, D., vander Pol, S. M. A., vanHet Hof, B. et al., P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma. Acta Neuropathol. 2014, 127: 699-711.
47. Kooij, G., Mizee, M. R., vanHorssen, J., Reijerkerk, A., Witte, M. E., Drexhage, J. A. R., vander Pol, S. M. A. et al., Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis. Brain 2011, 134: 555-570.
48. VanHorssen, J., Schreibelt, G., Drexhage, J., Hazes, T., Dijkstra, C. D., vander Valk, P. and DeVries, H. E., Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic. Biol. Med. 2008. 45: 1729-1737.
49. Witte, M. E., Bø, L., Rodenburg, R. J., Belien, J. A., Musters, R., Hazes, T., Wintjes, L. T. et al., Enhanced number and activity of mitochondria in multiple sclerosis lesions. J. Pathol. 2009. 219: 193-204.
50. VanHorssen, J., Vos, C. M. P., Admiraal, L., vanHaastert, E. S., Montagne, L., vander Valk, P. and deVries, H. E., Matrix metalloproteinase-19 is highly expressed in active multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 2006. 32: 585-593.
51. DeGroot, C. J. A., Montagne, L., Janssen, I., Ravid, R., VanDer Valk, P. and Veerhuis, R., Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue. Brain Res. Protoc. 2000. 5: 85-94.
52. Henderson, L. M. and Chappell, J. B., Dihydrorhodamine 123: a fluorescent probe for superoxide generation? Eur. J. Biochem. 1993. 217: 973-980.
53. Lisi, L., Stigliano, E., Lauriola, L., Navarra, P. and Dello Russo, C., Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells. ASN Neuro. 2014. DOI:10.1042/AN20130045 3: 171-183.
54. Zhang, H., Li, Y., Yu, J., Guo, M., Meng, J., Liu, C., Xie, Y. et al., Rho kinase inhibitor fasudil regulates microglia polarization and function. Neuroimmunomodulation. 2013. 20: 313-322.